Apex Biotechnology Corp
TWSE:1733

Watchlist Manager
Apex Biotechnology Corp Logo
Apex Biotechnology Corp
TWSE:1733
Watchlist
Price: 29.6 TWD 0.85% Market Closed
Market Cap: NT$3B

Operating Margin

7.9%
Current
Improving
by 0.6%
vs 3-y average of 7.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
7.9%
=
Operating Income
NT$155.5m
/
Revenue
NT$2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
7.9%
=
Operating Income
NT$155.5m
/
Revenue
NT$2B

Peer Comparison

Country Company Market Cap Operating
Margin
TW
Apex Biotechnology Corp
TWSE:1733
2.9B TWD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.8B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
186.8B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
137.9B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.8B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
130.2B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.6B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.8B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.7B USD
Loading...
US
Resmed Inc
NYSE:RMD
37B USD
Loading...

Market Distribution

In line with most companies in Taiwan
Percentile
60th
Based on 1 045 companies
60th percentile
7.9%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

Apex Biotechnology Corp
Glance View

Market Cap
3B TWD
Industry
Health Care

Apex Biotechnology Corp. engages in the research, development, manufacture and sell of biotechnological products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2001-09-17. The firm primarily provides testing strips and monitoring systems, including blood glucose monitoring systems, uric acid monitoring systems, pesticide residue detection systems, lactate monitoring systems and hemachrome testing systems, among others. Its blood glucose monitoring systems and uric acid monitoring systems are mainly used by patients, doctors and nurses in hospitals and clinics. The firm distributes its products in domestic market and to overseas markets, including the Americas, Europe and the rest of Asia.

Intrinsic Value
29.3 TWD
Overvaluation 1%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
7.9%
=
Operating Income
NT$155.5m
/
Revenue
NT$2B
What is Apex Biotechnology Corp's current Operating Margin?

The current Operating Margin for Apex Biotechnology Corp is 7.9%, which is above its 3-year median of 7.3%.

How has Operating Margin changed over time?

Over the last 3 years, Apex Biotechnology Corp’s Operating Margin has increased from 7.6% to 7.9%. During this period, it reached a low of 5.3% on Jun 30, 2024 and a high of 9.6% on Jun 30, 2025.

Back to Top